Q3 2012

Source filing unavailable

Q3 2012 · —

Revenue

$5.74M

no prior Q3 2011 on file

Net Income

-$2.53M

no prior Q3 2011 on file

EPS Diluted

-$0.13

no prior Q3 2011 on file

Operating Income$1,514,000—

Operating Cash Flowderived$6,937,000—

Same quarter

Metric	Q3 2012	Q3 2011	Q3 2010	Q3 2009
Revenue	$5.74M	$6.38M	$5.74M	$7.80M
Net Income	-$2.53M	-$194.00K	-$4.18M	-$11.84M
EPS Diluted	-$0.13	-$0.01	-$0.21	-$0.60

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR